| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | isonicotinohydroxamic acid | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | 0.001 | 1 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | 0.00074 | 1 |